PRINSTON INC FDA Approval ANDA 040574

ANDA 040574

PRINSTON INC

FDA Drug Application

Application #040574

Application Sponsors

ANDA 040574PRINSTON INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL25MG0HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2005-05-27
LABELING; LabelingSUPPL4AP2013-04-30STANDARD
LABELING; LabelingSUPPL7AP2014-06-04STANDARD
LABELING; LabelingSUPPL10AP2016-03-30STANDARD
LABELING; LabelingSUPPL13AP2016-11-08STANDARD

Submissions Property Types

SUPPL4Null15
SUPPL7Null15
SUPPL10Null7
SUPPL13Null7

TE Codes

001PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40574
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROXYZINE HYDROCHLORIDE","activeIngredients":"HYDROXYZINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROXYZINE HYDROCHLORIDE","submission":"HYDROXYZINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.